111 related articles for article (PubMed ID: 33901815)
21. Copy number variant hotspots in Han Taiwanese population induced pluripotent stem cell lines - lessons from establishing the Taiwan human disease iPSC Consortium Bank.
Huang CY; Li LH; Hsu WT; Cheng YC; Nicholson MW; Liu CL; Ting CY; Ko HW; Syu SH; Wen CH; Yan Z; Huang HP; Su HL; Chiang PM; Shen CN; Chen HF; Yen BLJ; Lu HE; Hwang SM; Chiou SH; Ho HN; Wu JY; Kamp TJ; Wu JC; Hsieh PCH
J Biomed Sci; 2020 Sep; 27(1):92. PubMed ID: 32887585
[TBL] [Abstract][Full Text] [Related]
22. Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.
Slamecka J; Salimova L; McClellan S; van Kelle M; Kehl D; Laurini J; Cinelli P; Owen L; Hoerstrup SP; Weber B
Cell Cycle; 2016; 15(2):234-49. PubMed ID: 26654216
[TBL] [Abstract][Full Text] [Related]
23. Derivation of Induced Pluripotent Stem Cell (iPSC) Lines from Patient-Specific Peripheral Blood Mononuclear Cells (PBMC) Using Episomal Vectors.
Konala VBR; Nandakumar S; Surendran H; Pal R
Methods Mol Biol; 2022; 2549():137-151. PubMed ID: 33772463
[TBL] [Abstract][Full Text] [Related]
24. Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood.
Zhou H; Martinez H; Sun B; Li A; Zimmer M; Katsanis N; Davis EE; Kurtzberg J; Lipnick S; Noggle S; Rao M; Chang S
Stem Cell Rev Rep; 2015 Aug; 11(4):652-65. PubMed ID: 25951995
[TBL] [Abstract][Full Text] [Related]
25. Differentiation of blood T cells: Reprogramming human induced pluripotent stem cells into neuronal cells.
Tsai PH; Chang YC; Lee YY; Ko YL; Yang YH; Lin CF; Chang YL; Yu WC; Shih YH; Chen MT
J Chin Med Assoc; 2015 Jun; 78(6):353-9. PubMed ID: 26022695
[TBL] [Abstract][Full Text] [Related]
26. Generation of three induced pluripotent stem cell (iPSC) lines from a multiple endocrine neoplasia type 1 (MEN1) patient and three iPSC lines from an unaffected relative of the patient.
Yoshida S; Okura H; Suga H; Nishitomi T; Sakurai A; Arima H; Matsuyama A
Stem Cell Res; 2020 Jul; 46():101846. PubMed ID: 32460232
[TBL] [Abstract][Full Text] [Related]
27. A highly optimized protocol for reprogramming cancer cells to pluripotency using nonviral plasmid vectors.
Zhao H; Davies TJ; Ning J; Chang Y; Sachamitr P; Sattler S; Fairchild PJ; Huang FP
Cell Reprogram; 2015 Feb; 17(1):7-18. PubMed ID: 25549177
[TBL] [Abstract][Full Text] [Related]
28. Generation of a human induced pluripotent stem cell line (HMGUi002-A) from a healthy male individual.
Wang X; Malinowski AR; Beckenbauer J; Siehler J; Blöchinger A; Meitinger T; Häring HU; Staiger H; Burtscher I; Lickert H
Stem Cell Res; 2019 Aug; 39():101531. PubMed ID: 31419739
[TBL] [Abstract][Full Text] [Related]
29. Optimization of episomal reprogramming for generation of human induced pluripotent stem cells from fibroblasts.
Bang JS; Choi NY; Lee M; Ko K; Lee HJ; Park YS; Jeong D; Chung HM; Ko K
Anim Cells Syst (Seoul); 2018; 22(2):132-139. PubMed ID: 30460090
[TBL] [Abstract][Full Text] [Related]
30. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
[TBL] [Abstract][Full Text] [Related]
31. Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies.
Nath SC; Menendez L; Friedrich Ben-Nun I
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069252
[TBL] [Abstract][Full Text] [Related]
32. A Comparative View on Easy to Deploy non-Integrating Methods for Patient-Specific iPSC Production.
Manzini S; Viiri LE; Marttila S; Aalto-Setälä K
Stem Cell Rev Rep; 2015 Dec; 11(6):900-8. PubMed ID: 26341105
[TBL] [Abstract][Full Text] [Related]
33. Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids.
Meraviglia V; Zanon A; Lavdas AA; Schwienbacher C; Silipigni R; Di Segni M; Chen HS; Pramstaller PP; Hicks AA; Rossini A
J Vis Exp; 2015 Jun; (100):e52885. PubMed ID: 26131963
[TBL] [Abstract][Full Text] [Related]
34. Generation of integration free human iPSC line SORMi002-A from neonatal foreskin fibroblasts.
Shivaraj A; Parveen S
Stem Cell Res; 2019 Oct; 40():101534. PubMed ID: 31454679
[TBL] [Abstract][Full Text] [Related]
35. Do Induced Pluripotent Stem Cell Characteristics Correlate with Efficient In Vitro Smooth Muscle Cell Differentiation? A Comparison of Three Patient-Derived Induced Pluripotent Stem Cell Lines.
Zhou Y; Kang G; Wen Y; Briggs M; Sebastiano V; Pederson R; Chen B
Stem Cells Dev; 2018 Oct; 27(20):1438-1448. PubMed ID: 30153084
[TBL] [Abstract][Full Text] [Related]
36. Generation of two human control iPS cell lines (UCLi016-A and UCLi017-A) from healthy donors with no known ocular conditions.
Méjécase C; Harding P; Sarkar H; Eintracht J; Lima Cunha D; Toualbi L; Moosajee M
Stem Cell Res; 2020 Dec; 49():102113. PubMed ID: 33370878
[TBL] [Abstract][Full Text] [Related]
37. Generation of control human iPSC line INSTEMi001-A from PBMCs of a healthy Indian donor.
Patlolla N; Ponnachan P; Jamora C; Abbey D
Stem Cell Res; 2023 Jun; 69():103112. PubMed ID: 37236122
[TBL] [Abstract][Full Text] [Related]
38. Generation of Integration-Free Induced Pluripotent Stem Cells from Urine-Derived Cells Isolated from Individuals with Down Syndrome.
M Lee Y; Zampieri BL; Scott-McKean JJ; Johnson MW; Costa ACS
Stem Cells Transl Med; 2017 Jun; 6(6):1465-1476. PubMed ID: 28371411
[TBL] [Abstract][Full Text] [Related]
39. Transgene-Free Disease-Specific iPSC Generation from Fibroblasts and Peripheral Blood Mononuclear Cells.
Fidan K; Ebrahimi A; Çağlayan ÖH; Özçimen B; Önder TT
Methods Mol Biol; 2016; 1353():215-31. PubMed ID: 26126451
[TBL] [Abstract][Full Text] [Related]
40. Umbilical Cord Tissue as a Source of Young Cells for the Derivation of Induced Pluripotent Stem Cells Using Non-Integrating Episomal Vectors and Feeder-Free Conditions.
Mohamed A; Chow T; Whiteley J; Fantin A; Sorra K; Hicks R; Rogers IM
Cells; 2020 Dec; 10(1):. PubMed ID: 33396312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
